BioIntervene
San Diego, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into BioIntervene
Sign up to find every way you can get introduced to BioIntervene
- Your email: who you already know at BioIntervene, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioIntervene team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
DS
Daniela SalveminiNamed on SEC filing
GJ
Gary J. BennettNamed on SEC filing
Board
EH
GP
Investors · 1
MPM BioImpactreportedBoston · $1M – $15Mvia Gary Patou · board
How we know: board seat on SEC Form D · funding news · globenewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$38.8M disclosed across 3 rounds · 2019–2021
- $30MSeries AJan 2020 · 4 sources
MPM Capital (lead)
Source ↗
▶$5.6MraisedJun 2021 · 3 investors · PharmaceuticalsRule 506(b)
▶$5.6MraisedJun 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ed HurwitzDirector
- Simon TateDirector
- Gary J. BennettDirector
- David BredtDirector
- Daniela SalveminiDirector
- Gary PatouDirector
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedMar 2019 · 5 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedMar 2019 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daniela SalveminiDirector
- Gary J. BennettExecutive Officer, Director
- Ed HurwitzDirector
- Gary PatouDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are BioIntervene's investors?
- BioIntervene's investors include MPM BioImpact.
- How much funding has BioIntervene raised?
- BioIntervene has disclosed $38.8M raised across 3 rounds.
- Where is BioIntervene headquartered?
- BioIntervene is headquartered in San Diego, US.
